Back to search
FDAFDA · Food and drugs·Recall number Z-2456-2012

***REF LS7700***Qty 1*** EC REP*** ConMed Linvatec Xenon Universal Light Source

Published October 3, 2012 · Recall initiated: May 20, 2011

Summary

FDA records medical device Class II recall Z-2456-2012, published October 3, 2012 and initiated May 20, 2011. Recalling firm: Linvatec Corp. dba ConMed Linvatec; Status: Terminated; Reported quantity: 57; Lot: GCT. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Linvatec Corporation dba ConMed Linvatec, Largo, FL initiated a recall of their products LS7700 Xenon Universal Light Source and LS7600 Xenon Light Source are intended to be used with an endoscope to provide illumination during endoscopic procedures.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Linvatec Corp. dba ConMed Linvatec
Distributor
Worldwide Distribution - US Nationwide and the countries of Canada, DK, HK, IN, IT, KR, MY, RU, CO, VN, ZA.
Lot
GCT
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ***REF LS7700***Qty 1*** EC REP*** ConMed Linvatec Xenon Universal Light Source recalled?

Yes. FDA published recall Z-2456-2012 on October 3, 2012. Reported hazard: Linvatec Corporation dba ConMed Linvatec, Largo, FL initiated a recall of their products LS7700 Xenon Universal Light Source and LS7600 Xenon Light Source are intended to be used with an endoscope to provide illumination during endoscopic procedures.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit